Xeris Pharmaceuticals | Capital Social Ordinario



Ordinary Share Capital Cambio Fecha
Adcock Ingram Holdings ZAR 14.68M 0 2024-12
Celltrion KRW 230.8B 10.29B 2025-03
Cspc Pharmaceutical CNY 11.03B 26.91M 2024-12
Dianthus Therapeutics USD 31K 2K 2024-12
Divis Laboratories Ltd 530M 0 2025-03
Eli Lilly USD 946.83M 354.23M 2025-06
Kangmei Pharma CNY 13.86B 0 2025-03
Knight Therapeutics CAD 539.32M 1.63M 2024-09
Laboratorios Farma EUR 3.24M 0 2023-06
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 115.01M 9.28M 2024-12
Neuren Pharmaceuticals AUD 165.27M 10.43M 2024-12
Organigram Holdings CAD 892.59M 39.7M 2024-12
Pacira USD 44.9M 44.85M 2025-06
Perrigo USD 137.6M 6.56B 2025-06
Pharma Mar EUR 17.58M 6.64M 2025-06
Qiagen NV USD 216.83M 214.3M 2025-06
Sartorius EUR 69.04M 38.2K 2025-06
Sino Biopharmaceutical CNY 414.38M 0 2024-12
Supernus Pharmaceuticals USD 56.12M 130K 2025-06
Tilray USD 93K 5K 2024-11
Zz Pientze Pharmaceu 603.32M 0 2025-03


Xeris Pharmaceuticals Capital Social Ordinario - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.